BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

427 related articles for article (PubMed ID: 25381793)

  • 1. Fragmented QRS predicts heart failure progression in patients with hypertrophic cardiomyopathy.
    Nomura A; Konno T; Fujita T; Tanaka Y; Nagata Y; Tsuda T; Hodatsu A; Sakata K; Nakamura H; Kawashiri MA; Fujino N; Yamagishi M; Hayashi K
    Circ J; 2015; 79(1):136-43. PubMed ID: 25381793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. QRS Fragmentation and QTc Duration Relate to Malignant Ventricular Tachyarrhythmias and Sudden Cardiac Death in Patients with Hypertrophic Cardiomyopathy.
    Debonnaire P; Katsanos S; Joyce E; VAN DEN Brink OV; Atsma DE; Schalij MJ; Bax JJ; Delgado V; Marsan NA
    J Cardiovasc Electrophysiol; 2015 May; 26(5):547-55. PubMed ID: 25648421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Outcomes in Patients With Nonobstructive, Labile, and Obstructive Hypertrophic Cardiomyopathy.
    Lu DY; Pozios I; Haileselassie B; Ventoulis I; Liu H; Sorensen LL; Canepa M; Phillip S; Abraham MR; Abraham TP
    J Am Heart Assoc; 2018 Feb; 7(5):. PubMed ID: 29478967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fragmented QRS as a candidate marker for high-risk assessment in hypertrophic cardiomyopathy.
    Kang KW; Janardhan AH; Jung KT; Lee HS; Lee MH; Hwang HJ
    Heart Rhythm; 2014 Aug; 11(8):1433-40. PubMed ID: 24813377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early repolarization as a predictor of arrhythmic and nonarrhythmic cardiac events in middle-aged subjects.
    Junttila MJ; Tikkanen JT; Kenttä T; Anttonen O; Aro AL; Porthan K; Kerola T; Rissanen HA; Knekt P; Huikuri HV
    Heart Rhythm; 2014 Oct; 11(10):1701-6. PubMed ID: 24858812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fragmented QRS complex predicts the arrhythmic events in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia.
    Canpolat U; Kabakçi G; Aytemir K; Dural M; Sahiner L; Yorgun H; Sunman H; Bariş Kaya E; Tokgözoğlu L; Oto A
    J Cardiovasc Electrophysiol; 2013 Nov; 24(11):1260-6. PubMed ID: 23845044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic difference between paroxysmal and non-paroxysmal atrial fibrillation in patients with hypertrophic cardiomyopathy.
    Yashiro B; Minami Y; Terajima Y; Hagiwara N
    J Cardiol; 2014 Jun; 63(6):432-7. PubMed ID: 24280311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New Appearance of Fragmented QRS as a Predictor of Ventricular Arrhythmic Events in Patients With Hypertrophic Cardiomyopathy.
    Ogura S; Nakamura K; Morita H; Toh N; Nakagawa K; Yoshida M; Watanabe A; Nishii N; Miyoshi T; Ito H
    Circ J; 2020 Feb; 84(3):487-494. PubMed ID: 32037379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Characteristics and Long-Term Outcomes of Hypertrophic Cardiomyopathy.
    Yoshinaga M; Yoshikawa D; Ishii H; Hirashiki A; Okumura T; Kubota A; Sakai S; Harada K; Somura F; Mizuno T; Fujiwara W; Yokoi H; Hayashi M; Ishii J; Ozaki Y; Murohara T; Yoshida Y; Amano T; Izawa H
    Int Heart J; 2015; 56(4):415-20. PubMed ID: 26084460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Obesity With Adverse Long-term Outcomes in Hypertrophic Cardiomyopathy.
    Fumagalli C; Maurizi N; Day SM; Ashley EA; Michels M; Colan SD; Jacoby D; Marchionni N; Vincent-Tompkins J; Ho CY; Olivotto I;
    JAMA Cardiol; 2020 Jan; 5(1):65-72. PubMed ID: 31693057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of hypertrophic cardiomyopathy.
    Enriquez AD; Goldman ME
    Ann Glob Health; 2014; 80(1):35-45. PubMed ID: 24751563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ventricular tachyarrhythmia associated with hypertrophic cardiomyopathy: incidence, prognosis, and relation to type of hypertrophy.
    Furushima H; Chinushi M; Iijima K; Sanada A; Izumi D; Hosaka Y; Aizawa Y
    J Cardiovasc Electrophysiol; 2010 Sep; 21(9):991-9. PubMed ID: 20487113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sarcomere gene mutations are associated with increased cardiovascular events in left ventricular hypertrophy: results from multicenter registration in Japan.
    Fujita T; Fujino N; Anan R; Tei C; Kubo T; Doi Y; Kinugawa S; Tsutsui H; Kobayashi S; Yano M; Asakura M; Kitakaze M; Komuro I; Konno T; Hayashi K; Kawashiri MA; Ino H; Yamagishi M
    JACC Heart Fail; 2013 Dec; 1(6):459-66. PubMed ID: 24621997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of QRS fragmentation in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia.
    Peters S; Truemmel M; Koehler B
    J Cardiovasc Med (Hagerstown); 2012 May; 13(5):295-8. PubMed ID: 22450866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of Outcomes in Patients With Nonobstructive, Labile-Obstructive, and Chronically Obstructive Hypertrophic Cardiomyopathy.
    Pozios I; Corona-Villalobos C; Sorensen LL; Bravo PE; Canepa M; Pisanello C; Pinheiro A; Dimaano VL; Luo H; Dardari Z; Zhou X; Kamel I; Zimmerman SL; Bluemke DA; Abraham MR; Abraham TP
    Am J Cardiol; 2015 Sep; 116(6):938-44. PubMed ID: 26239580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical significance of new-onset atrial fibrillation in patients with hypertrophic cardiomyopathy.
    Kubo T; Baba Y; Ochi Y; Hirota T; Yamasaki N; Kawai K; Yamamoto K; Kondo F; Bando K; Yamada E; Furuno T; Yabe T; Doi YL; Kitaoka H
    ESC Heart Fail; 2021 Dec; 8(6):5022-5030. PubMed ID: 34472710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. J Waves for Predicting Cardiac Events in Hypertrophic Cardiomyopathy.
    Tsuda T; Hayashi K; Konno T; Sakata K; Fujita T; Hodatsu A; Nagata Y; Teramoto R; Nomura A; Tanaka Y; Furusho H; Takamura M; Kawashiri MA; Fujino N; Yamagishi M
    JACC Clin Electrophysiol; 2017 Oct; 3(10):1136-1142. PubMed ID: 29759496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spectrum and prognostic significance of arrhythmias on ambulatory Holter electrocardiogram in hypertrophic cardiomyopathy.
    Adabag AS; Casey SA; Kuskowski MA; Zenovich AG; Maron BJ
    J Am Coll Cardiol; 2005 Mar; 45(5):697-704. PubMed ID: 15734613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical course of hypertrophic cardiomyopathy in a non selected population. The Experience of the Italian Multicenter Cardiomyopathy Study].
    Cecchi F; Olivotto I; Lazzeroni E; Chiriatti G; Sachero A; Beretta L; Giagnoni E; Renosto G; Montereggi A; Baldassarre S; Castelli G; Ciaccheri M
    G Ital Cardiol; 1997 Nov; 27(11):1133-43. PubMed ID: 9463057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of the association between the presence of fragmented QRS and the predicted risk score of sudden cardiac death at 5 years in patients with hypertrophic cardiomyopathy.
    Özyılmaz S; Akgül Ö; Uyarel H; Pusuroğlu H; Karayakalı M; Gül M; Çetin M; Satılmışoğlu H; Yıldırım A; Bakır İ
    Anatol J Cardiol; 2017 Jul; 18(1):54-61. PubMed ID: 28559533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.